March Recruitment News!
Spring has arrived, and alongside new flowers it also brought along new sites for OCTOPUS!
Check out the Sites page to learn more about the new sites currently in trial set up.
There are now 22 participants have been screened and 17 randomised for Analysis Stage 2 (AS2), bringing the total for both stages up to 452 participants randomised and 535 participants screened!
Check out the table below to see how each site is doing as of 31-March-2025:
| Site | Number Screened | Number Randomised |
| UCLH (London) | 155 | 133 |
| University Hospital Southampton (Southampton) | 62 | 43 |
| The Anne Rowling Regenerative Neurology clinic (Edinburgh) | 63 | 51 |
| Royal Hallamshire Hospital (Sheffield) | 35 | 30 |
| Belfast City Hospital (Belfast) | 54 | 47 |
| Leeds General Infirmary (Leeds) | 29 | 25 |
| University of Wales (Cardiff) | 20 | 19 |
| Poole Hospital (Poole) | 20 | 18 |
| University Hospital Coventry and Warwickshire (Coventry) | 36 | 31 |
| Royal Victoria Infirmary (Newcastle) | 15 | 12 |
| Queens Medical Centre (Nottingham) | 18 | 17 |
| Addenbrooke’s Hospital (Cambridge) | 10 | 9 |
| Morriston Hospital (Swansea) | 11 | 11 |
| Southmead Hospital (Bristol) | 5 | 5 |
| Queen's Hospital (Romford) | 2 | 2 |
| Total | 535 | 452 |
